Is RVTY or TMO more undervalued in 2026?

CirclFi compares Revvity, Inc. (RVTY) and Thermo Fisher Scientific Inc (TMO) using 13 institutional-grade valuation models. RVTY has a Quality of Company score of 8.2/10 while TMO scores 9.0/10.

Which is a better buy — RVTY or TMO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RVTY and TMO valuations compare?

RVTY at $101.22 and TMO at $487.22 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RVTY vs TMO Valuation Comparison 2026 — Intrinsic Value Analysis

RVTY

Diagnostics & Research

Revvity, Inc.

Quality

8.2

out of 10

Value Trap

LOW

Price

$101.22

Last close

Models

11/13

Active

TMO

Diagnostics & Research

Thermo Fisher Scientific Inc

Quality

9.0

out of 10

Value Trap

SAFE

Price

$487.22

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	RVTY Fair Value	RVTY Upside	TMO Fair Value	TMO Upside
Bayesian DCF	Intrinsic	$95.11	-6.0%	$222.35	-54.4%
Earnings Power Value	Intrinsic	$56.11	-44.6%	$28.34	-94.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RVTY vs TMO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RVTY vs TMO — Which Stock Is More Undervalued?

TMO scores higher with a 9.0/10 quality rating vs RVTY's 8.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Revvity, Inc. (RVTY) and Thermo Fisher Scientific Inc (TMO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RVTY currently trades at $101.22 with a QOC of 8.2/10, while TMO trades at $487.22 with a QOC of 9.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).